By Benjamin Chiou
Date: Tuesday 14 Oct 2025
(Sharecast News) - Pharma giant GSK has received regulatory approval in China to expand the use of its Shingrix shingles vaccine, the company announced on Tuesday.
SCHEME OF ARRANGEMENT BECOMES EFFECTIVE | 15-Oct-2025 | 18:25 | RNS |
Holding(s) in Company | 15-Oct-2025 | 16:57 | RNS |
Form 8.5 (EPT/RI)-Spectris plc Amend | 15-Oct-2025 | 16:20 | RNS |
Director/PDMR Shareholding | 15-Oct-2025 | 15:30 | RNS |
Form 8.3 - SPT LN | 15-Oct-2025 | 15:30 | RNS |
Questor:Meggitt | 23-Dec-2014 | Telegraph |
Questor :KCOM | 27-Nov-2014 | Telegraph |
Questor :Ricardo | 31-Oct-2014 | Telegraph |
Questor:CSR | 17-Oct-2014 | Telegraph |
Questor:BAE Systems | 03-Sep-2014 | Telegraph |
Price | 5,537.69 |
Change Today | -10.27 |
% Change | -0.19 % |
15-Oct-25 Close | 5,537.69 |
You are here: research